First Manhattan CO Bausch Health Companies Inc. Transaction History

First Manhattan CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.28 - $9.85 $6,280 - $9,850	1,000 New	1,000 $8,000
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $32,400 - $41,685	-1,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $80,500 - $101,535	-3,500 Reduced 70.0%	1,500 $41,000
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $12,520 - $15,030	500 Added 11.11%	5,000 $139,000
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $41,145 - $49,050	1,500 Added 50.0%	4,500 $131,000
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $64,110 - $103,140	3,000 New	3,000 $95,000
Q3 2019 Nov 13, 2019	SELL	$20.88 - $25.66 $709 - $872	-34 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$20.64 - $25.67 $701 - $872	34 New	34 $0

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.